Not a good buy right now for an impatient trader: there’s no proprietary “strong buy” trigger today, and near-term momentum is starting to fade (MACD rolling negative) while options positioning skews defensive.
The setup looks more like a range/mean-reversion trade around ~$31.8–$31.95 than a clean breakout buy.
Technical Analysis
Price is sitting right around the pivot (~31.879) with very tight nearby levels: S1 31.837 / S2 31.811 and R1 31.921 / R2 31.947.
Trend (medium/long-term): bullish with moving averages stacked SMA_5 > SMA_20 > SMA_200, suggesting the broader structure is constructive.
Momentum (short-term): weakening: MACD histogram -0.00725 and negatively expanding implies fading upside momentum despite the bullish MA structure.
RSI(6) ~52.45 (neutral): no clear overbought/oversold edge.
Pattern-based expectation: ~-1.01% next week, ~+3.8% next month → near-term chop/softness before a potentially better upswing.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Open interest is heavily put-skewed (Put OI 7892 vs Call OI 2173; OI P/C 3.63) → sentiment leans bearish/hedged.
Today’s options volume is call-only (Call vol 100, Put vol 0; volume P/C 0) → not a broad bearish “rush,” more like existing put positioning dominating outstanding contracts.
IV (30d) ~54.44 with IV percentile ~31 / IV rank ~26 → IV is not extreme; options market isn’t pricing a major volatility spike from here.
Volume vs 30D avg is elevated (~161%) but on small absolute volume, so conviction signal is limited.
Technical Summary
Sell
2
Buy
12
Positive Catalysts
Broader MA structure is bullish (SMA_5 > SMA_20 > SMA_200), which can support dips.
Latest quarter showed much higher EPS and net income YoY, which can attract value/quality screens depending on sustainability.
No negative newsflow in the last week provided (no fresh headline-driven overhang identified).
Neutral/Negative Catalysts
Earnings just occurred (2026-02-04 after hours), and the provided snapshot shows revenue down -22.15% YoY (a clear top-line contraction).
MACD weakening suggests buyers may be losing control in the very near term.
Put-heavy open interest (P/C 3.63) indicates notable downside hedging/defensive positioning.
Hedge funds and insiders are neutral (no supportive accumulation signal in the supplied data).
Financial Performance
2025/Q4 results (latest provided):
Revenue: $652.1M, -22.15% YoY (negative growth trend on the top line).
Net income: $75.7M, +418.49% YoY.
EPS: $1.06, +404.76% YoY.
Gross margin: 31.79%, +1.31% YoY.
Takeaway: profitability metrics surged while revenue fell sharply—this often points to mix, cost actions, or one-time items, so the quality of earnings is a key question (not answered by the provided data).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating changes or price target updates were provided in the dataset, so a recent trend summary cannot be confirmed.
Wall Street “pros vs cons” view based only on the provided fundamentals/technicals:
Pros: improving margins and sharply higher EPS/NI YoY; bullish MA stack.
Wall Street analysts forecast HI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HI is 32 USD with a low forecast of 32 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast HI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HI is 32 USD with a low forecast of 32 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
Current: 31.880
Low
32
Averages
32
High
32
Current: 31.880
Low
32
Averages
32
High
32
CJS Securities
Outperform -> Market Perform
downgrade
$32
AI Analysis
2025-10-16
Reason
CJS Securities
Price Target
$32
AI Analysis
2025-10-16
downgrade
Outperform -> Market Perform
Reason
CJS Securities downgraded Hillenbrand to Market Perform from Outperform with a $32 price target after the company agreed be acquired by an affiliate of Lone Star Funds in an all-cash transaction valued at $32.00 per share.
DA Davidson
Matt Summerville
Neutral
maintain
$24 -> $32
2025-10-16
Reason
DA Davidson
Matt Summerville
Price Target
$24 -> $32
2025-10-16
maintain
Neutral
Reason
DA Davidson analyst Matt Summerville raised the firm's price target on Hillenbrand to $32 from $24 and keeps a Neutral rating on the shares after the company announced it entered into a definitive agreement to be acquired by Lone Star Funds in an all-cash transaction valuing the enterprise at about $3.8B or $32.00 per share.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HI
